Opsens Inc. (OPSSF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Opsens Inc. (OPSSF) trades at $2.14 with AI Score 58/100 (Grade B). Opsens Inc. specializes in fiber optic sensors for medical and industrial applications, with a focus on cardiovascular interventions. Market cap: $247.43M, Sector: Healthcare.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for OPSSF: OPSSF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates OPSSF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
OPSSF: 1/4 perspectives are bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →Opsens Inc. (OPSSF) Healthcare & Pipeline Overview
Opsens Inc. develops and markets fiber optic sensors, primarily for cardiovascular applications, alongside industrial uses. With a 57.9% gross margin, the company serves a global market through direct sales and distributors, positioning itself in the niche medical and industrial sensor technology sector.
What Is the Investment Thesis for OPSSF?
Opsens Inc. presents a focused investment opportunity within the niche market of fiber optic sensors, particularly for medical applications. The company's high gross margin of 57.9% indicates strong pricing power and efficient operations. Growth catalysts include the increasing adoption of minimally invasive surgical techniques and the expansion of industrial applications for fiber optic sensors. However, the negative P/E ratio of -26.89 and a negative profit margin of -25.7% highlight profitability challenges. Investors should monitor the company's ability to scale its operations and achieve profitability while navigating competition and regulatory hurdles in the medical device industry. The company's beta of 0.32 suggests lower volatility compared to the broader market.
Based on FMP financials and quantitative analysis
OPSSF Key Highlights
- Market capitalization of $247.43M, reflecting its size and market value within the medical instruments and supplies industry.
- Gross margin of 57.9%, indicating a strong ability to control production costs and maintain pricing power.
- Negative P/E ratio of -26.89, suggesting the company is currently not profitable.
- Beta of 0.32, indicating lower volatility compared to the overall market.
- Operates in two segments: Medical and Industrial, diversifying its revenue streams and market reach.
Who Are OPSSF's Competitors?
OPSSF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BTMD biote Corp. | $2.25 | +3.92% | $99.46M | 74 |
| CSSPF NIOX Group Plc | $0.75 | +0.00% | $315.65M | 47 |
| DLHTF Dialogue Health Technologies Inc. | $3.79 | +0.59% | $254.80M | 56 |
| FPHAF Faron Pharmaceuticals Oy | $3.30 | +0.00% | $209.54M | 44 |
| GUERF Guerbet S.A. | $22.25 | +0.00% | $281.03M | 43 |
| NYXH Nyxoah S.A. | $1.75 | +1.74% | $69.31M | 69 |
| KMTS Kestra Medical Technologies, Ltd. | $27.70 | +2.67% | $1.62B | 67 |
| ZTEK Zentek Ltd. | $0.46 | +2.88% | $49.90M | 63 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are OPSSF's Key Strengths?
- Proprietary fiber optic sensor technology.
- Strong gross margin of 57.9%.
- Diversified revenue streams through medical and industrial segments.
- Global sales and distribution network.
What Are OPSSF's Weaknesses?
- Negative P/E ratio indicating current lack of profitability.
- Reliance on distributors for sales.
- Limited brand recognition compared to larger competitors.
- Dependence on regulatory approvals for medical devices.
What Could Drive OPSSF Stock Higher?
- New product launches in the cardiovascular intervention market expected in Q4 2026.
- Expansion of the distribution network in Asia-Pacific, anticipated to increase sales by 15% in 2027.
- Increasing adoption of fiber optic sensors in industrial applications, driven by demand for structural health monitoring.
- Potential partnerships with medical device companies to integrate Opsens' technology into their products, expected by mid-2027.
- Research and development efforts focused on next-generation sensor technology, with potential breakthroughs in accuracy and reliability.
What Are the Key Risks for OPSSF?
- Negative return on equity (-36.4%) — the business is not currently generating profit on shareholder capital.
- Inconsistent delivery — missed Wall Street EPS estimates in 5 of the last 5 reported quarters.
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Competition from established medical device manufacturers with greater resources.
- Technological obsolescence if Opsens fails to innovate and adapt to changing market needs.
- Changes in healthcare reimbursement policies that could affect the demand for Opsens' products.
- Economic downturn affecting industrial demand for fiber optic sensors.
- Regulatory hurdles and compliance costs associated with medical device approvals.
What Are the Growth Opportunities for OPSSF?
- Expansion in Cardiovascular Interventions: Opsens can capitalize on the growing market for minimally invasive cardiovascular procedures. The increasing prevalence of heart diseases and the demand for less invasive treatment options drive this market. By enhancing its fiber optic sensor technology for guiding and monitoring these procedures, Opsens can increase its market share. This expansion is supported by ongoing research and development in cardiovascular medicine, with a potential market size exceeding $20 billion by 2028.
- Penetration of Industrial Markets: Opsens has opportunities to expand its presence in industrial sectors such as energy, aerospace, and defense. Fiber optic sensors are increasingly used for monitoring structural health, temperature, pressure, and strain in these industries. By tailoring its sensor solutions to meet the specific needs of these sectors, Opsens can diversify its revenue streams and reduce its reliance on the medical market. The industrial sensor market is projected to reach $30 billion by 2027.
- Strategic Partnerships and Acquisitions: Opsens can pursue strategic partnerships with medical device companies and industrial equipment manufacturers to integrate its sensor technology into their products. Acquisitions of complementary technology providers can also enhance its product portfolio and market reach. These partnerships can provide access to new markets and distribution channels, accelerating its growth. The timeline for realizing these opportunities depends on the availability of suitable partners and acquisition targets.
- Geographic Expansion: Opsens can expand its sales and distribution network in emerging markets, such as Asia-Pacific and Latin America, where the demand for advanced medical devices and industrial sensors is growing. Establishing a local presence in these markets can improve its competitiveness and responsiveness to customer needs. This expansion requires investments in sales and marketing infrastructure, with a potential timeline of 3-5 years to establish a significant presence.
- Development of Next-Generation Sensors: Opsens can invest in research and development to develop next-generation fiber optic sensors with improved accuracy, reliability, and functionality. These sensors can address unmet needs in the medical and industrial markets and provide a competitive advantage. The development of new sensors requires ongoing investments in research and development, with a potential timeline of 2-3 years to bring new products to market.
What Opportunities Does OPSSF Have?
- Expansion in minimally invasive cardiovascular procedures.
- Penetration of industrial markets with sensor solutions.
- Strategic partnerships and acquisitions.
- Geographic expansion in emerging markets.
What Threats Does OPSSF Face?
- Competition from established medical device manufacturers.
- Technological obsolescence.
- Changes in healthcare reimbursement policies.
- Economic downturn affecting industrial demand.
What Are OPSSF's Competitive Advantages?
- Proprietary fiber optic sensor technology.
- Strong relationships with medical device companies.
- Established distribution network.
- Expertise in cardiovascular applications.
What Does OPSSF Do?
Opsens Inc., originally named Capital DCB inc. and rebranded in 2006, was founded in 2003 and is headquartered in Québec, Canada. The company specializes in developing, manufacturing, and distributing fiber optic sensors. These sensors are primarily used in cardiovascular interventions within the medical sector and various industrial applications. Opsens operates through two main segments: Medical and Industrial. The Medical segment focuses on providing precise sensor technologies for guiding and monitoring minimally invasive cardiovascular procedures. The Industrial segment offers solutions for industries such as energy, aerospace and defense, industrial and laboratory, smart structure health monitoring, geotechnical, and power electronics and semiconductors. Opsens' product portfolio includes fiber optic temperature, pressure, strain, and displacement sensors, as well as fiber optic extensometers and signal conditioner/OEM boards. These products are sold globally through a network of distributors and a direct sales force, covering markets in the United States, Japan, Canada, and other international regions. Opsens aims to enhance the precision and reliability of medical procedures and industrial processes through its advanced sensor technology.
What Products and Services Does OPSSF Offer?
- Develops fiber optic sensors for medical applications.
- Manufactures sensors for cardiovascular interventions.
- Offers sensors for industrial applications.
- Provides fiber optic temperature sensors.
- Provides fiber optic pressure sensors.
- Provides fiber optic strain sensors.
- Provides fiber optic displacement sensors.
- Sells products through distributors and direct sales.
How Does OPSSF Make Money?
- Sells fiber optic sensors to medical device companies.
- Sells fiber optic sensors to industrial clients.
- Generates revenue through direct sales and distributor networks.
What Industry Does OPSSF Operate In?
Opsens Inc. operates in the medical instruments and supplies industry, which is characterized by technological innovation and stringent regulatory requirements. The market for fiber optic sensors in medical applications is growing, driven by the increasing demand for minimally invasive surgical procedures and advanced diagnostic tools. The company competes with other medical device manufacturers and sensor technology providers. The industry is also influenced by healthcare spending trends and reimbursement policies.
Who Are OPSSF's Key Customers?
- Medical device manufacturers.
- Hospitals and clinics.
- Energy companies.
- Aerospace and defense companies.
0/5 beatsEarnings Track Record
Opsens Inc. has missed Wall Street's EPS estimate in 5 of its last 5 reported quarters — a recurring pattern of falling short of estimates. Reported results have landed about 37.0% below estimates on average.
OPSSF Valuation & Market Position
With a $247.43M market cap, Opsens Inc. sits in the micro-cap segment of the market. Relative to its peer group, OPSSF's quantitative score of 58/100 is roughly in line with the peer average of 53/100.
ROE -36%Key Financial Metrics
Return on equity for Opsens Inc. stands at -36.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -24.4%, showing how much profit it generates from its asset base. Its free cash flow yield is -5.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 4.42 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -3.7%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 2/9Financial Health
Opsens Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 11.42 places it in the safe zone, indicating low near-term bankruptcy risk.
Company Profile
Opsens Inc. operates in the Medical - Instruments & Supplies industry within the Healthcare sector. It is headquartered in Québec, CA. The company is led by CEO Louis Laflamme CPA, CPA. OPSSF has traded publicly since 2012.
OPSSF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Proprietary fiber optic sensor technology.
- Strong gross margin of 57.9%.
- Diversified revenue streams through medical and industrial segments.
- Global sales and distribution network.
Bear Case
- Negative P/E ratio indicating current lack of profitability.
- Reliance on distributors for sales.
- Limited brand recognition compared to larger competitors.
- Dependence on regulatory approvals for medical devices.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
OPSSF Latest News
No recent news available for OPSSF.
OPSSF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for OPSSF.
Price Targets
Wall Street price target analysis for OPSSF.
OPSSF MoonshotScore
What does this score mean?
The MoonshotScore rates OPSSF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Louis Laflamme CPA, CPA
CEO
Louis Laflamme is a CPA, CPA, and serves as the Chief Executive Officer of Opsens Inc. His background includes extensive experience in financial management and corporate leadership. Prior to joining Opsens, he held various senior financial positions in other companies, bringing a wealth of knowledge in accounting, finance, and strategic planning. His expertise is crucial in guiding Opsens' financial strategy and driving its growth initiatives.
Track Record: Under Louis Laflamme's leadership, Opsens Inc. has focused on expanding its market presence in both the medical and industrial sectors. Key achievements include strengthening the company's distribution network and driving innovation in fiber optic sensor technology. His strategic decisions have contributed to the company's revenue growth and improved operational efficiency. He manages a team of 293 employees.
OPSSF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Opsens Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure.
- Lower liquidity and higher price volatility.
- Potential for fraud or manipulation.
- Lack of regulatory oversight.
- Going concern risk.
- Verify the company's financial statements and SEC filings.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Review the company's legal and regulatory compliance.
- Evaluate the company's liquidity and trading volume.
- Check for any red flags or warning signs.
- Consult with a financial advisor.
- Established business operations since 2003.
- Presence in the medical and industrial sectors.
- Global sales and distribution network.
- Proprietary fiber optic sensor technology.
- Management team with relevant experience.
What Investors Ask About Opsens Inc. (OPSSF) — Healthcare
What does Opsens Inc. do?
Opsens Inc. specializes in developing, manufacturing, and selling fiber optic sensors for both medical and industrial applications. The company's medical segment focuses on providing precise sensor technologies for minimally invasive cardiovascular procedures, while the industrial segment caters to sectors like energy, aerospace, and defense. Opsens' products include fiber optic temperature, pressure, strain, and displacement sensors, sold globally through distributors and a direct sales force.
What are the main risks for OPSSF?
Opsens Inc. faces several risks, including competition from larger medical device manufacturers, technological obsolescence, and changes in healthcare reimbursement policies. The company's reliance on distributors for sales also poses a risk. Additionally, economic downturns could affect industrial demand for fiber optic sensors. Regulatory hurdles and compliance costs associated with medical device approvals represent ongoing challenges. Investors should carefully assess these risks before investing in OPSSF.
What are the key factors to evaluate for OPSSF?
Opsens Inc. (OPSSF) holds an AI score of 58/100 (moderate). Not financial advice.
How frequently does OPSSF data refresh on this page?
OPSSF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven OPSSF's recent stock price performance?
Opsens Inc. (OPSSF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary fiber optic sensor technology. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider OPSSF overvalued or undervalued right now?
Valuing Opsens Inc. (OPSSF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying OPSSF?
Before investing in Opsens Inc. (OPSSF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding OPSSF to a portfolio?
Key strength of Opsens Inc. (OPSSF): Proprietary fiber optic sensor technology. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- OTC market data may have limited availability and accuracy.
- Analyst opinions are based on general industry trends and may not reflect specific company analysis.